Welcome to Medications.com

Flonase News

The ragweed rampage - The Casper Star Tribune

If symptoms are moderate, Shah recommends a prescription nasal corticosteroid such as Singulair or Flonase. Just remember to start any medicine early in the ...

Posted: Tue Oct 02 01:18:02 -0400 2007

Nose feeling tickly? It could be ragweed - MetroWest Daily News

However, some people may need to get relief from steroid inhalers, known by names such as Nasonex, Flonase and Nasocort. Baksh also mentioned a second ...

http://www.metrowestdailynews.com... | Posted: Mon Sep 10 13:26:42 -0400 2007

Nose feeling tickly? It could be ragweed - MetroWest Daily News

However, some people may need to get relief from steroid inhalers, known by names such as Nasonex, Flonase and Nasocort. Baksh also mentioned a second ...

Posted: Mon Sep 10 13:26:42 -0400 2007

Ragweed season may be among worst in decades - Fort Worth Star Telegram

all 2 news articles

Posted: Thu Sep 06 03:26:05 -0400 2007

Morgan Stanley underweight on Cipla; target Rs 195 - Moneycontrol.com

It is awaiting approval of generic Flonase for its partner for the US launch. US tie-ups span 10 players, 91 ANDAs filed, another 20-25 filings and 10 more ...

http://www.moneycontrol.com/india... | Posted: Wed Aug 29 07:27:53 -0400 2007

DSP Merrill Lynch maintains sell on Cipla - Moneycontrol.com

... trend to continue given lack of visibility on big product upsides (eg generic Flonase approval which is long pending for US) and weak quarters ahead. ...

http://www.moneycontrol.com/india... | Posted: Wed Aug 29 07:27:58 -0400 2007

Morgan Stanley underweight on Cipla; target Rs 195 - Moneycontrol.com (press release)

It is awaiting approval of generic Flonase for its partner for the US launch. US tie-ups span 10 players, 91 ANDAs filed, another 20-25 filings and 10 more ...

http://news.moneycontrol.com/indi... | Posted: Wed Aug 29 13:02:10 -0400 2007

DSP Merrill Lynch maintains sell on Cipla - Moneycontrol.com

... trend to continue given lack of visibility on big product upsides (eg generic Flonase approval which is long pending for US) and weak quarters ahead. ...

Posted: Wed Aug 29 07:27:58 -0400 2007

Morgan Stanley underweight on Cipla; target Rs 195 - Moneycontrol.com (press release)

It is awaiting approval of generic Flonase for its partner for the US launch. US tie-ups span 10 players, 91 ANDAs filed, another 20-25 filings and 10 more ...

Posted: Wed Aug 29 13:02:10 -0400 2007

DSP Merrill Lynch maintains sell on Cipla - Moneycontrol.com

... trend to continue given lack of visibility on big product upsides (eg generic Flonase approval which is long pending for US) and weak quarters ahead. ...

Posted: Wed Aug 29 07:27:58 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea